FAB: Omega-3 and Schizophrenia

Omega-3 for Depression & Dementia: The Devil is in the Detail - BOOK HERE

Omega-3 and Schizophrenia - Research

Saugstad 2006 - Are neurodegenerative disorders and psychotic manifestations avoidable with adequate dietary omega-3?
Vaddadi 2006 - Essential fatty acids and mental illness.
Vaddadi et al 2006 - Tardive dyskinesia and essential fatty acids
du Bois et al 2005 - Membrane phospholipid composition, alterations in neurotransmitter systems and schizophrenia.
Peet 2004 - International variations in schizophrenia outcome and depression prevalence in relation to national diet
Peet 2003 - EPA in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results.
Raine et al 2003 - Effects of Environmental Enrichment at Ages 3-5 Years on Schizotypal Personality and Antisocial Behavior at Ages 17 and 23 Years
Cunnane & Crawford - 2003 - Survival of the fattest: fat babies were the key to evolution of the large human brain.
Richardson 2003 - Omega 3 fatty acids in behaviour, cognition and mood
Haag 2003 - Essential fatty acids and the brain.
Peet 2003 - Nutrition and schizophrenia: an epidemiological and clinical perspective.
Peet & Horrobin 2002 - A dose-ranging study of EPA treatment in schizophrenia
Horrobin et al 2002 - Eicosapentaenoic acid and arachidonic acid: collaboration and not antagonism is the key to biological understanding.
Assies et al 2001 - Reduced DHA and DPA in red cell membranes in schizophrenia
Bennett & Horrobin 2000 - Gene targets for phospholipid metabolism in psychiatric disorders: an update.
MacDonell et al 2000 - Increased cytosolic PLA2 in dyslexia
Ross 2000 - Oxidative stress in neurodevelopmental disorders
Ward 2000 - Potential diagnostic aids for fatty acid abnormalities in developmental disorders
Richardson et al 2000 - Blood fatty acid changes following EPA treatment in schizophrenia
Fenton et al 2000 - EFAs, lipid membrane abnormalities, and schizophrenia
Puri et al 2000 - EPA treatment in schizophrenia associated with symptom remission, normalisation of blood fatty acids, reduced neuronal membrane phospholipid turnover and structural brain changes.
Richardson et al 1999 - Laterality changes in schizophrenia following EPA treatment
Horrobin & Bennett 1999 - Gene targets for phospholipid metabolism in psychiatric disorders
Horrobin 1998 - The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia
Puri & Richardson 1998 - Sustained remission of schizophrenia symptoms following EPA treatment.
Peet et al 1996 - Essential fatty acid deficiency in erythrocyte membranes from chronic schizophrenic patients, and the clinical effects of dietary supplementation
Vaddadi et al 1996 - Schizophrenia, tardive dyskinesia and essential fatty acids
Horrobin et al 1994 - The membrane hypothesis of schizophrenia
Rudin 1982 - The dominant diseases of modernized societies as omega-3 essential fatty acid deficiency syndrome: substrate beriberi
Rudin 1981 - The major psychoses and neuroses as omega-3 essential fatty acid deficiency syndrome: substrate pellagra

Food and Behaviour Research is a registered charity (No SC034604) and a company limited by guarantee (Co No SC 253448)

Newsletter Signup

Useful Links

Contact Us

FAB Research
23 Carlton Road
Oxford
OX2 7SA

Important Notice

Medical opinion and guidance should always be sought for any symptoms that might possibly reflect a known or suspected disease, disorder or medical condition. Information provided on this website (or by FAB Research via any other means) does not in any way constitute advice on the treatment of any medical condition formally diagnosed or otherwise.